Pharmacokinetic and safety profile of tofacitinib in children with polyarticular course juvenile idiopathic arthritis: results of a phase 1, open-label, multicenter study.

Abstract

Authors

• Nicolino Ruperto
  Istituto Giannina Gaslini, Clinica Pediatrica e Reumatologia, PRINTO, Genoa, Italy. nicolaruperto@gaslini.org.
• Hermine I Brunner
  Cincinnati Children's Hospital Medical Center, PRCSG, Cincinnati, OH, USA.
• Zbigniew Zuber
  St Louis Children's Hospital ODS Rheumatology and Neurology, Krakow, Poland.
• Nikolay Tzaribachev
  Pediatric Rheumatology Research Institute, Bad Bramstedt, Germany.
• Daniel J Kingsbury
  Randall Children's Hospital, Portland, OR, USA.
• Ivan Foeldvari
  Hamburger Zentrum für Kinder- und Jugendrheumatologie, Hamburg, Germany.
• Gerd Horneff
  Centre of General Pediatrics and Neonatology, Asklepios Klinik, Sankt Augustin, Germany.
• Elzbieta Smolewska
  Department of Pediatric Rheumatology, Medical University of Lodz, Lodz, Poland.
• Richard K Vehe
  University of Minnesota Masonic Children's Hospital, Minneapolis, MN, USA.
• Anasuya Hazra
  Pfizer Inc, Collegeville, PA, USA.
• Rong Wang
  College of Food Science and Engineering, Northwest A&F University, Yangling 712100, Shanxi, China. Electronic address: wangrong91@nwsuaf.edu.cn.
• Charles A Mebus
  Pfizer Inc, Groton, CT, USA.
• Christine Alvey
  Pfizer Inc, Groton, CT, USA.
• Manisha Lamba
  Pfizer Inc, Groton, CT, USA.
• Sriram Krishnaswami
  Pfizer Inc, Groton, CT, USA.
• Thomas C Stock
  Pfizer Inc, Collegeville, PA, USA.
• Min Wang
  National and Local Joint Engineering Research Center of Ecological Treatment Technology for Urban Water Pollution, Wenzhou University, Wenzhou 325035, China.
• Ricardo Suehiro
  Pfizer Inc, Collegeville, PA, USA.
• Alberto Martini
  University of Genoa, Italy.
• Daniel J Lovell
  Cincinnati Children's Hospital Medical Center, PRCSG, Cincinnati, OH, USA.

Keywords

External Resources